GPCR NewsOct 1, 20221 minGPCR Binders, Drugs, and moreDiscovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..October 2022 Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for...
GPCR NewsOct 1, 20221 minReviews, GPCRs, and moreNanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled ReceptorsOctober 2022 "Understanding the activation of G protein-coupled receptors (GPCRs) is of paramount importance to the field of...
GPCR NewsOct 1, 20222 minReviews, GPCRs, and moreAdrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate AffairOctober 2022 "Systolic heart failure (HF) is a chronic clinical syndrome characterized by the reduction in cardiac function and still...
GPCR NewsOct 1, 20221 minReviews, GPCRs, and morePepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular SystemOctober 2022 "Pepducins are small-lipidated peptides designed from the intracellular loops of G protein-coupled receptors (GPCRs) that...